ENDRA Life Sciences Inc. 4/A
4/A · ENDRA Life Sciences Inc. · Filed Jun 28, 2017
Insider Transaction Report
Form 4/AAmended
Michelon Francois Roger
DirectorChief Executive Officer
Transactions
- Award
Stock Options
2017-06-09+31,960→ 31,960 totalExercise: $4.55Exp: 2025-05-12→ Common Stock (31,960 underlying)
Footnotes (2)
- [F1]These Stock Options become exercisable in three equal annual installments beginning on May 12, 2018.
- [F2]This amendment is being filed to correct the expiration date of these Stock Options, which was inadvertantly reported as May 12, 2022. The correct expiration date is May 12, 2025.